Market Cap 8.72M
Revenue (ttm) 16.02M
Net Income (ttm) 3.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 22.41%
Debt to Equity Ratio 0.00
Volume 52,600
Avg Vol 48,102
Day's Range N/A - N/A
Shares Out 3.43M
Stochastic %K 59%
Beta -0.67
Analysts Strong Sell
Price Target $11.00

Company Profile

Kiora Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, engages in the development and commercialization of therapies for the treatment of ophthalmic diseases. Its lead product is KIO-301, a potential vision-restoring small molecule, which is in Phase 2 clinical trials for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. The company is also developing KIO-104, a non-steroidal, immuno-modulatory, small-molecule inhibitor of dihydroorotate dehydr...

Industry: Biotechnology
Sector: Healthcare
Phone: 858 224 9600
Address:
332 Encinitas Boulevard, Suite 102, Encinitas, United States
Jake140
Jake140 Oct. 24 at 10:11 AM
0 · Reply
JoshThe3rd
JoshThe3rd Oct. 23 at 6:04 PM
$KPRX Earnings should be around November 8th. Hoping enrollment for KIO-104 is complete. Priced so low because the market doesn't like trial execution. But as you've seen it just takes a spark to ignite this.
0 · Reply
romarcin23
romarcin23 Oct. 22 at 5:45 PM
$KPRX @kprx. Do you think this dramatic fall is due to insider info? or over all market trend?
1 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR has optionality baked in. Real estate gives downside protection. A story shift (tokenization of assets, digital‑asset holdings, lease re‑ratings) gives upside. At current levels, the range up to $10+, even $13+, starts feeling very plausible when the market recognizes it. $VCIG $AVTX $YOSH $KPRX
0 · Reply
frontiere
frontiere Oct. 20 at 1:08 PM
$KPRX Kiora ref=$2.71 — slowly building Long size — catalysts far but chart Lindy and at support , neg EV (MCap<cash till 2027 at least) w low float. From 2025-09-15 S-3 mixed shelf https://www.sec.gov/Archives/edgar/data/1372514/000137251425000072/s-3xseptember2025.htm
0 · Reply
Ling23
Ling23 Oct. 20 at 9:18 AM
$KPRX Does anyone know Stephen From?? I believe he was with this company?
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 15 at 5:22 PM
GIPR is trading like real estate, but there’s potential for so much more. Assets under the hood + possibility of a crypto treasury pivot = upside few are pricing in. If they lean into digital assets, this could re-rate dramatically. $SNMP $MODD $CEI $KPRX $MBRX
0 · Reply
Jake140
Jake140 Oct. 15 at 12:15 PM
0 · Reply
newsfile_corp
newsfile_corp Oct. 15 at 11:01 AM
https://nfne.ws/270410 $KPRX #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing
0 · Reply
Jake140
Jake140 Oct. 13 at 11:13 AM
$KPRX Patience is key with this one...holding!
0 · Reply
Latest News on KPRX
Bonds still bouncing along

Sep 9, 2024, 4:55 PM EDT - 1 year ago

Bonds still bouncing along

CPLS EYEG HYFI JPST TLT USHY YEAR


AllianceBernstein Launches Five New Active ETFs

Dec 13, 2023, 7:30 AM EST - 2 years ago

AllianceBernstein Launches Five New Active ETFs

AB BUFC CPLS EYEG TAFL TAFM


Jake140
Jake140 Oct. 24 at 10:11 AM
0 · Reply
JoshThe3rd
JoshThe3rd Oct. 23 at 6:04 PM
$KPRX Earnings should be around November 8th. Hoping enrollment for KIO-104 is complete. Priced so low because the market doesn't like trial execution. But as you've seen it just takes a spark to ignite this.
0 · Reply
romarcin23
romarcin23 Oct. 22 at 5:45 PM
$KPRX @kprx. Do you think this dramatic fall is due to insider info? or over all market trend?
1 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 22 at 8:51 AM
GIPR has optionality baked in. Real estate gives downside protection. A story shift (tokenization of assets, digital‑asset holdings, lease re‑ratings) gives upside. At current levels, the range up to $10+, even $13+, starts feeling very plausible when the market recognizes it. $VCIG $AVTX $YOSH $KPRX
0 · Reply
frontiere
frontiere Oct. 20 at 1:08 PM
$KPRX Kiora ref=$2.71 — slowly building Long size — catalysts far but chart Lindy and at support , neg EV (MCap<cash till 2027 at least) w low float. From 2025-09-15 S-3 mixed shelf https://www.sec.gov/Archives/edgar/data/1372514/000137251425000072/s-3xseptember2025.htm
0 · Reply
Ling23
Ling23 Oct. 20 at 9:18 AM
$KPRX Does anyone know Stephen From?? I believe he was with this company?
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 15 at 5:22 PM
GIPR is trading like real estate, but there’s potential for so much more. Assets under the hood + possibility of a crypto treasury pivot = upside few are pricing in. If they lean into digital assets, this could re-rate dramatically. $SNMP $MODD $CEI $KPRX $MBRX
0 · Reply
Jake140
Jake140 Oct. 15 at 12:15 PM
0 · Reply
newsfile_corp
newsfile_corp Oct. 15 at 11:01 AM
https://nfne.ws/270410 $KPRX #Chemicals #Pharmaceutical #Biotechnology #Medical #Pharmaceuticals #NASDAQ #Investing
0 · Reply
Jake140
Jake140 Oct. 13 at 11:13 AM
$KPRX Patience is key with this one...holding!
0 · Reply
ThirstyFishy
ThirstyFishy Oct. 10 at 12:41 AM
$KPRX This company is so small that it can easily triple it's market cap in a single day. I expect it to happen, but I don't know when, so I'm just going to wait until it happens because it will happen
1 · Reply
JamesBenjaMin
JamesBenjaMin Oct. 7 at 1:07 AM
This is a rare setup PRHI trading at its bottom, daily golden cross coming, and the short data backing the squeeze narrative. The upside range is wide, and with few shares to borrow, every bit of buying pressure can fuel big moves. $PRFX $SNMP $KPRX $MGAM $OPGN
0 · Reply
Jake140
Jake140 Oct. 5 at 2:12 PM
0 · Reply
rangeyuri
rangeyuri Oct. 5 at 9:25 AM
$KPRX Biotech with clinical catalyst. High volatility expected. Trading near cash value. Speculative positioning.
0 · Reply
TradeHuntFish
TradeHuntFish Oct. 3 at 1:52 AM
GIPR could morph from underpriced REIT to digital treasury giant. Imagine it holding Bitcoin, Ethereum, or stablecoins on its balance sheet while still collecting real estate income. That hybrid model could lead to massive revaluation especially in a market chasing yield + digital assets. $VEEE $AVTX $KPRX $WKEY $GNS
0 · Reply
Jake140
Jake140 Oct. 1 at 10:46 AM
$KPRX Liking the premarket activity today! This stock flies quietly under the radar but just wait...
0 · Reply
enzomassimi
enzomassimi Sep. 30 at 3:21 PM
0 · Reply
Jake140
Jake140 Sep. 30 at 2:39 PM
$KPRX On the move...finally! Hope it holds...
0 · Reply
Jake140
Jake140 Sep. 25 at 6:31 AM
0 · Reply
TradeHuntFish
TradeHuntFish Sep. 17 at 11:39 AM
EDUC Balance sheet is clean. Chart is curled. $EDUC just pulled off a $32M sale and eliminated bank debt with no dilution…. This is how real runners start: strong, silent, and ready to explode. $CRKN $AVTX $VCIG $KPRX $YOSH
0 · Reply
TradeHuntFish
TradeHuntFish Sep. 17 at 10:34 AM
EDUC is one of the cleanest setups in small caps: – No dilution – $32M in real estate sale complete – Generating real cash – Debt eliminated Chart has range to $5$12 this is how quiet runners start. $PRFX $FNGR $INPX $WLDS $KPRX
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Sep. 17 at 9:26 AM
EDUC is quietly building strength: → ~$3M free cash flow → Inventory cleaned up = $11M in cash → Debt reduced by $17M → No dilution risk Add that to a bottomed chart and a multi-year range to $7+, and this becomes a true sleeper. $CXAI $SOUN $VCIG $MITQ $KPRX
0 · Reply